India Dupixent Market Size & Outlook, 2025-2033

The dupixent market in India is expected to reach a projected revenue of US$ 743.5 million by 2033. A compound annual growth rate of 13.7% is expected of India dupixent market from 2025 to 2033.
Revenue, 2024 (US$M)
$231.6
Forecast, 2033 (US$M)
$743.5
CAGR, 2025 - 2033
13.7%
Report Coverage
India

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

India dupixent market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

India dupixent market highlights

  • The India dupixent market generated a revenue of USD 231.6 million in 2024 and is expected to reach USD 743.5 million by 2033.
  • The India market is expected to grow at a CAGR of 13.7% from 2025 to 2033.
  • In terms of segment, atopic dermatitis (ad) was the largest revenue generating type in 2024.
  • COPD is the most lucrative type segment registering the fastest growth during the forecast period.


Dupixent market data book summary

Market revenue in 2024USD 231.6 million
Market revenue in 2033USD 743.5 million
Growth rate13.7% (CAGR from 2025 to 2033)
Largest segmentAtopic dermatitis (ad)
Fastest growing segmentCOPD
Historical data2021 - 2023
Base year2024
Forecast period2025 - 2033
Quantitative unitsRevenue in USD million
Market segmentationAtopic Dermatitis (AD), Asthma, CRSwNP, COPD, Other


Other key industry trends

  • In terms of revenue, India accounted for 1.6% of the global dupixent market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In Asia Pacific, Japan dupixent market is projected to lead the regional market in terms of revenue in 2033.
  • China is the fastest growing regional market in Asia Pacific and is projected to reach USD 534.4 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Dupixent Market Companies

Name Profile # Employees HQ Website
Regeneron Pharmaceuticals Inc View profile 13450 777 Old Saw Mill River Road, Tarrytown, NY, United States, 10591-6707 https://www.regeneron.com
Sanofi SA View profile 87994 46, avenue de la Grande Armée, Paris, France, 75017 https://www.sanofi.com

India dupixent market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dupixent market will help companies and investors design strategic landscapes.


Atopic dermatitis (ad) was the largest segment with a revenue share of 80.27% in 2024. Horizon Databook has segmented the India dupixent market based on atopic dermatitis (ad), asthma, crswnp, copd, other covering the revenue growth of each sub-segment from 2021 to 2033.


Reasons to subscribe to India dupixent market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of India dupixent market databook

  • Our clientele includes a mix of dupixent market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the India dupixent market , including forecasts for subscribers. This country databook contains high-level insights into India dupixent market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

India dupixent market size, by type, 2021-2033 (US$M)

India Dupixent Market Outlook Share, 2024 & 2033 (US$M)

India dupixent market size, by type, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online